Mirae Asset Global Investments
ALXO icon

Mirae Asset Global Investments’s ALX Oncology ALXO Stock Holding History

Mirae Asset Global Investments’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,905
Closed -$3.75K – 1594
2024
Q3 		$3.75K Buy
1,905
+350
+23% +$1.3K ﹤0.01% 1525
2024
Q2 		$9.07K Sell
1,555
-9,382
-86% -$115K ﹤0.01% 1466
2024
Q1 		$62.6K Buy
10,937
+235
+2% +$3.3K ﹤0.01% 2417
2023
Q4 		$159K Buy
10,702
+277
+3% +$2.63K ﹤0.01% 2381
2023
Q3 		$50K Buy
10,425
+43
+0.4% +$233 ﹤0.01% 2549
2023
Q2 		$78K Sell
10,382
-81
-0.8% -$530 ﹤0.01% 2562
2023
Q1 		$47.3K Sell
10,463
-26
-0.2% -$197 ﹤0.01% 2513
2022
Q4 		$118K Buy
+10,489
New +$118K ﹤0.01% 2429

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

Mirae Asset Global Investments's ALXO Position: Q4 2024 in Review

Mirae Asset Global Investments sold out of ALX Oncology (ALXO) in Q4 2024, closing a stake of 1,905 shares — an estimated $3.75K sold.

Mirae Asset Global Investments first reported a position in ALXO in Q4 2022 and held it in 8 quarters. The position peaked at $159K in Q4 2023. 87 funds tracked by Wall St. Rank hold ALXO as of Q4 2024.

  • Mirae Asset Global Investments reported no remaining ALX Oncology position as of Q4 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 1,905 ALX Oncology shares in Q4 2024, an estimated $3.75K.
  • Mirae Asset Global Investments first reported a position in ALX Oncology in Q4 2022 and held it in 8 quarters.
  • Mirae Asset Global Investments's ALX Oncology position peaked at $159K in Q4 2023.
  • 87 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2024.

Based on Mirae Asset Global Investments's 13F filing for Q4 2024, filed 27 Jan 2025.